ArticleFrontiers in medicine2026
The therapeutic effect of IPL on children with vernal keratoconjunctivitis.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To observe the effectiveness of intense pulsed light (IPL) treatment as an adjuvant treatment of vernal keratoconjunctivitis (VKC) in children. Methods: Sixty-two children diagnosed with VKC from January 2022 to November 2024 were selected and divided into the IPL group (27 cases, conventional drug therapy combined with IPL treatment) and the control group (35 cases, conventional drug therapy). Symptom and sign indicators were tested before treatment (baseline) and after the end of treatment. The Treatment course, recurrence time and the number of adverse reactions for each group of patients were recorded. Result: There was no statistically significant difference in the treatment course between the two groups ( Conclusion: IPL can effectively prolong the recurrence interval of VKC, and has good safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.